This paper has been posted here (i think) in the past
https://www.frontiersin.org/articles/10.3389/fonc.2021.671880/full
Conclusion: CLE with a rigid handheld probe is easy and intuitive to handle during panendoscopy. As next step, the high accuracy of ex vivo CLE image classification for tumor tissue suggests the validation of CLE in vivo. This will evolve CLE as a complementary tool for in vivo intraoperative diagnosis during panendoscopy.
The following paper has only recently been published from work in the same area using Cellvizio
It is worth comparing the conclusions from both papers if only to reinforce the strengths of Convivo (Optiscan CLE) over the competition!
https://link.springer.com/article/10.1007/s00784-021-04156-4Conclusion
- Forums
- ASX - By Stock
- OIL
- compare the two
OIL
optiscan imaging limited
Add to My Watchlist
1.19%
!
8.5¢

compare the two
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.001(1.19%) |
Mkt cap ! $71.00M |
Open | High | Low | Value | Volume |
8.4¢ | 8.5¢ | 8.3¢ | $3.899K | 46.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 0.084 |
2 | 39552 | 0.083 |
1 | 42500 | 0.081 |
4 | 117512 | 0.080 |
3 | 176500 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 50000 | 1 |
0.093 | 10000 | 1 |
0.095 | 50000 | 1 |
0.100 | 103621 | 2 |
0.105 | 242487 | 3 |
Last trade - 15.24pm 12/09/2025 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |